Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Glycobac Medical Equipment Supplied In Usa
4 equipment items found
Manufactured by:GlycoBac, LLC based inLaramie, WYOMING (USA)
Sf-RVN is an Sf-rhabdovirus-free S. frugiperda cell line that can seamlessly replace the widely used, but persistently virally contaminated Sf9 or Sf21 cell lines for recombinant protein or rAAV production. ...
Manufactured by:GlycoBac, LLC based inLaramie, WYOMING (USA)
Available expression plasmids include pAcp(+) and pAcp(-) series transfer plasmids1, which allow for production of baculovirus vectors for the expression of your gene of interest in the immediate/early phase of ...
Manufactured by:GlycoBac, LLC based inLaramie, WYOMING (USA)
pIE1HRX is a versatile, compact expression plasmid that is designed for transient or stable expression of the gene of interest in insect cell lines. pIE1HRX is a 3.9 kb vector derived with a compact multiple cloning site and an efficient minimal baculovirus p10 gene polyadenylation ...
Manufactured by:GlycoBac, LLC based inLaramie, WYOMING (USA)
Available cell lines include Sf9 (Spodoptera frugiperda), TN368 (Trichoplusia ni), and glycoengineered cell lines derived from Sf9 that are able to produce glycoproteins with mammalian-type glycan profiles. The latter are still under development, but may be made available on a case-by-case basis. Further insect cell lines are also being developed to address specific problems faced by users of ...
